In the wake of the financial crisis and the so-called ‘shareholder-spring’ of 2012 (a period during which many shareholders refused to endorse directors’ remuneration policies), the government has introduced new rules on directors’ remuneration reporting. The new rules: (i) increase the compliance burdens regarding the reporting of directors’ remuneration policies; (ii) increase shareholder control over remuneration and termination packages; and (iii) introduce potential personal liability for directors who authorise payments in violation of an approved policy.
These changes bound certain UK-incorporated quoted Life Sciences companies with effect from 1 October 2013. The government estimates that around 900 companies have been affected.
Continue Reading New Directors’ Remuneration Regime: The Facts for Life Sciences Companies